Cargando…
A methodology review on the incremental prognostic value of computed tomography biomarkers in addition to Framingham risk score in predicting cardiovascular disease: the use of association, discrimination and reclassification
BACKGROUND: Computed tomography (CT) biomarkers claim to improve cardiovascular risk stratification. This review focuses on significant differences in incremental measures between adequate and inadequate reporting practise. METHODS: Studies included were those that used Framingham Risk Score as a ba...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822603/ https://www.ncbi.nlm.nih.gov/pubmed/29466951 http://dx.doi.org/10.1186/s12872-018-0777-5 |
_version_ | 1783301722295238656 |
---|---|
author | Pang, Chun Lap Pilkington, Nicola Wei, Yinghui Peters, Jaime Roobottom, Carl Hyde, Chris |
author_facet | Pang, Chun Lap Pilkington, Nicola Wei, Yinghui Peters, Jaime Roobottom, Carl Hyde, Chris |
author_sort | Pang, Chun Lap |
collection | PubMed |
description | BACKGROUND: Computed tomography (CT) biomarkers claim to improve cardiovascular risk stratification. This review focuses on significant differences in incremental measures between adequate and inadequate reporting practise. METHODS: Studies included were those that used Framingham Risk Score as a baseline and described the incremental value of adding calcium score or CT coronary angiogram in predicting cardiovascular risk. Searches of MEDLINE, EMBASE, Web of Science and Cochrane Central were performed with no language restriction. RESULTS: Thirty five studies consisting of 206,663 patients (men = 118,114, 55.1%) were included. The baseline Framingham Risk Score included the 1998, 2002 and 2008 iterations. Selective reporting, inconsistent reference groupings and thresholds were found. Twelve studies (34.3%) had major and 23 (65.7%) had minor alterations and the respective Δ AUC were significantly different (p = 0.015). When the baseline model performed well, the Δ AUC was relatively lower with the addition of a CT biomarker (Spearman coefficient = − 0.46, p < 0.0001; n = 33; 76 pairs of data). Other factors that influenced AUC performance included exploration of data analysis, calibration, validation, multivariable and AUC documentation (all p < 0.05). Most studies (68.7%) that reported categorical NRI (n = 16; 46 pairs of data) subjectively drew strong conclusions along with other poor reporting practices. However, no significant difference in values of NRI was found between adequate and inadequate reporting. CONCLUSIONS: The widespread practice of poor reporting particularly association, discrimination, reclassification, calibration and validation undermines the claimed incremental value of CT biomarkers over the Framingham Risk Score alone. Inadequate reporting of discrimination inflates effect estimate, however, that is not necessarily the case for reclassification. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12872-018-0777-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5822603 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58226032018-02-26 A methodology review on the incremental prognostic value of computed tomography biomarkers in addition to Framingham risk score in predicting cardiovascular disease: the use of association, discrimination and reclassification Pang, Chun Lap Pilkington, Nicola Wei, Yinghui Peters, Jaime Roobottom, Carl Hyde, Chris BMC Cardiovasc Disord Research Article BACKGROUND: Computed tomography (CT) biomarkers claim to improve cardiovascular risk stratification. This review focuses on significant differences in incremental measures between adequate and inadequate reporting practise. METHODS: Studies included were those that used Framingham Risk Score as a baseline and described the incremental value of adding calcium score or CT coronary angiogram in predicting cardiovascular risk. Searches of MEDLINE, EMBASE, Web of Science and Cochrane Central were performed with no language restriction. RESULTS: Thirty five studies consisting of 206,663 patients (men = 118,114, 55.1%) were included. The baseline Framingham Risk Score included the 1998, 2002 and 2008 iterations. Selective reporting, inconsistent reference groupings and thresholds were found. Twelve studies (34.3%) had major and 23 (65.7%) had minor alterations and the respective Δ AUC were significantly different (p = 0.015). When the baseline model performed well, the Δ AUC was relatively lower with the addition of a CT biomarker (Spearman coefficient = − 0.46, p < 0.0001; n = 33; 76 pairs of data). Other factors that influenced AUC performance included exploration of data analysis, calibration, validation, multivariable and AUC documentation (all p < 0.05). Most studies (68.7%) that reported categorical NRI (n = 16; 46 pairs of data) subjectively drew strong conclusions along with other poor reporting practices. However, no significant difference in values of NRI was found between adequate and inadequate reporting. CONCLUSIONS: The widespread practice of poor reporting particularly association, discrimination, reclassification, calibration and validation undermines the claimed incremental value of CT biomarkers over the Framingham Risk Score alone. Inadequate reporting of discrimination inflates effect estimate, however, that is not necessarily the case for reclassification. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12872-018-0777-5) contains supplementary material, which is available to authorized users. BioMed Central 2018-02-21 /pmc/articles/PMC5822603/ /pubmed/29466951 http://dx.doi.org/10.1186/s12872-018-0777-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Pang, Chun Lap Pilkington, Nicola Wei, Yinghui Peters, Jaime Roobottom, Carl Hyde, Chris A methodology review on the incremental prognostic value of computed tomography biomarkers in addition to Framingham risk score in predicting cardiovascular disease: the use of association, discrimination and reclassification |
title | A methodology review on the incremental prognostic value of computed tomography biomarkers in addition to Framingham risk score in predicting cardiovascular disease: the use of association, discrimination and reclassification |
title_full | A methodology review on the incremental prognostic value of computed tomography biomarkers in addition to Framingham risk score in predicting cardiovascular disease: the use of association, discrimination and reclassification |
title_fullStr | A methodology review on the incremental prognostic value of computed tomography biomarkers in addition to Framingham risk score in predicting cardiovascular disease: the use of association, discrimination and reclassification |
title_full_unstemmed | A methodology review on the incremental prognostic value of computed tomography biomarkers in addition to Framingham risk score in predicting cardiovascular disease: the use of association, discrimination and reclassification |
title_short | A methodology review on the incremental prognostic value of computed tomography biomarkers in addition to Framingham risk score in predicting cardiovascular disease: the use of association, discrimination and reclassification |
title_sort | methodology review on the incremental prognostic value of computed tomography biomarkers in addition to framingham risk score in predicting cardiovascular disease: the use of association, discrimination and reclassification |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822603/ https://www.ncbi.nlm.nih.gov/pubmed/29466951 http://dx.doi.org/10.1186/s12872-018-0777-5 |
work_keys_str_mv | AT pangchunlap amethodologyreviewontheincrementalprognosticvalueofcomputedtomographybiomarkersinadditiontoframinghamriskscoreinpredictingcardiovasculardiseasetheuseofassociationdiscriminationandreclassification AT pilkingtonnicola amethodologyreviewontheincrementalprognosticvalueofcomputedtomographybiomarkersinadditiontoframinghamriskscoreinpredictingcardiovasculardiseasetheuseofassociationdiscriminationandreclassification AT weiyinghui amethodologyreviewontheincrementalprognosticvalueofcomputedtomographybiomarkersinadditiontoframinghamriskscoreinpredictingcardiovasculardiseasetheuseofassociationdiscriminationandreclassification AT petersjaime amethodologyreviewontheincrementalprognosticvalueofcomputedtomographybiomarkersinadditiontoframinghamriskscoreinpredictingcardiovasculardiseasetheuseofassociationdiscriminationandreclassification AT roobottomcarl amethodologyreviewontheincrementalprognosticvalueofcomputedtomographybiomarkersinadditiontoframinghamriskscoreinpredictingcardiovasculardiseasetheuseofassociationdiscriminationandreclassification AT hydechris amethodologyreviewontheincrementalprognosticvalueofcomputedtomographybiomarkersinadditiontoframinghamriskscoreinpredictingcardiovasculardiseasetheuseofassociationdiscriminationandreclassification AT pangchunlap methodologyreviewontheincrementalprognosticvalueofcomputedtomographybiomarkersinadditiontoframinghamriskscoreinpredictingcardiovasculardiseasetheuseofassociationdiscriminationandreclassification AT pilkingtonnicola methodologyreviewontheincrementalprognosticvalueofcomputedtomographybiomarkersinadditiontoframinghamriskscoreinpredictingcardiovasculardiseasetheuseofassociationdiscriminationandreclassification AT weiyinghui methodologyreviewontheincrementalprognosticvalueofcomputedtomographybiomarkersinadditiontoframinghamriskscoreinpredictingcardiovasculardiseasetheuseofassociationdiscriminationandreclassification AT petersjaime methodologyreviewontheincrementalprognosticvalueofcomputedtomographybiomarkersinadditiontoframinghamriskscoreinpredictingcardiovasculardiseasetheuseofassociationdiscriminationandreclassification AT roobottomcarl methodologyreviewontheincrementalprognosticvalueofcomputedtomographybiomarkersinadditiontoframinghamriskscoreinpredictingcardiovasculardiseasetheuseofassociationdiscriminationandreclassification AT hydechris methodologyreviewontheincrementalprognosticvalueofcomputedtomographybiomarkersinadditiontoframinghamriskscoreinpredictingcardiovasculardiseasetheuseofassociationdiscriminationandreclassification |